Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genes”

5,079 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,079 results

Testing effectiveness (Phase 2)UnknownNCT05005468
What this trial is testing

A Phase II Trial of Camrelizumab Combined With Famitinib for Adjuvant Treatment of Stage II-IIIA NSCLC.

Who this might be right for
NSCLC
Shanghai Chest Hospital 61
Not applicableStudy completedNCT02284074
What this trial is testing

Nasal LPS Challenge in Healthy Volunteers

Who this might be right for
Healthy
Imperial College London 15
Post-approval studies (Phase 4)Study completedNCT06869382
What this trial is testing

ICS+LABA Vs. ICS+LABA+Omalizumab: Impact on Asthma Control and Gene Expression

Who this might be right for
Asthma Patients
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation 26
Not applicableUnknownNCT00173069
What this trial is testing

A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES)

Who this might be right for
Schizophrenia
National Taiwan University Hospital 324
Early research (Phase 1)Study completedNCT02193191
What this trial is testing

Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Looking for participantsNCT06728410
What this trial is testing

A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

Who this might be right for
Intrahepatic CholangiocarcinomaFGFR2 Gene RearrangementFGFR2 Gene Mutation
Mehmet Akce 38
Not applicableStudy completedNCT01085227
What this trial is testing

Clinical, Molecular and by Neuroimaging of LRRK2 Mutations

Who this might be right for
Parkinson's Disease
Institut National de la Santé Et de la Recherche Médicale, France 50
Not applicableUnknownNCT04278027
What this trial is testing

Cognitive Remediation Therapy in Schizophrenia: Effects on Epigenetics

Who this might be right for
Schizophrenia
Hospital Clinic of Barcelona 60
Large-scale testing (Phase 3)Study completedNCT00478647
What this trial is testing

Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase

Who this might be right for
Gaucher Disease
Shire 40
Testing effectiveness (Phase 2)Study completedNCT04042558
What this trial is testing

A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies

Who this might be right for
NSCLC Stage IIIBNSCLC Stage IVEGFR Gene Mutation+2 more
Centre Francois Baclesse 150
Not applicableStudy completedNCT00873678
What this trial is testing

Assessment of the Prevalence of Genes AHI1, NPHP1 and CEP290 in Joubert Syndrome

Who this might be right for
Joubert SyndromeCerebello-oculo-renal Syndromes
Assistance Publique - Hôpitaux de Paris 80
Not applicableLooking for participantsNCT04160455
What this trial is testing

Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.

Who this might be right for
AutophagyGalectinsHIV Infections+1 more
Centre Hospitalier Régional d'Orléans 180
Testing effectiveness (Phase 2)Study completedNCT00237185
What this trial is testing

The Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene

Who this might be right for
Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST)
Novartis Pharmaceuticals 148
Large-scale testing (Phase 3)Active Not RecruitingNCT04281485
What this trial is testing

Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Pfizer 114
Testing effectiveness (Phase 2)Study completedNCT00074997
What this trial is testing

An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 Infection

Who this might be right for
HIV-1
Janssen-Cilag Pty Ltd 1
Not applicableStudy completedNCT07613879
What this trial is testing

Mulligan Mobilization and Stabilization Exercises for Sensorimotor Function in Women With Text Neck Syndrome

Who this might be right for
Neck PainText Neck SyndromeCumulative Trauma Disorders+1 more
Pamukkale University 38
Not applicableWithdrawnNCT02663648
What this trial is testing

Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders

Who this might be right for
Myeloproliferative DisordersPolycythemia VeraEssential Thrombocythemia+2 more
Shandong University
Not applicableStudy completedNCT01380925
What this trial is testing

The Jewels in Our Genes Study - an African American Family Study of Breast Cancer

Who this might be right for
Breast Cancer
University at Buffalo 330
Not applicableStudy completedNCT03814915
What this trial is testing

Diabetes Research on Patient Stratification

Who this might be right for
Type2 Diabetes
Lund University 3,049
Not applicableLooking for participantsNCT07261891
What this trial is testing

Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders

Who this might be right for
Primary Immunodeficiency Diseases (PID)
prof. dr. Rik Schrijvers 20
Load More Results